Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF | V.TLT.W

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Post by enriquesuaveon Dec 08, 2021 12:47pm
625 Views
Post# 34211015

BTD

BTDLet's hope they file for BTD soon and maybe with patients 24 and 25 also CR?  That would be awesome and could hopefully  lead to an early Accelerated FDA approval a year later. IMO. Maybe some news on GLP for GBM/ NSCLC?  By the time next Quarterly arrives, if data on next 7 patients is as good as 1st 11, then we should fly past $1 especially if BTD is granted by then, then we may see $3 or more as that would be a very good indication that chances of AA are high. IMO of course and no one can really tell how SP will react, but it's been done before, and we would clearly have the goods.  
<< Previous
Bullboard Posts
Next >>